The role of alpha-synuclein in nucleolar DNA double-strand break repair and cellular senescence

项目总结 基因组稳定性与与衰老相关的疾病密切相关，如神经退化和癌症。 有趣的是，强有力的证据表明这两种疾病之间有意想不到的联系，因为流行病学 研究发现，帕金森氏症(PD)患者患黑色素瘤的风险增加。 此外，这种关系是双向的；被诊断为黑色素瘤的人患黑色素瘤的风险增加。 发展中的PD。尽管这些临床关联已经确立，但细胞和分子通路 人们对这些疾病之间的联系知之甚少。帕金森病是第二常见的神经退行性疾病 与遗传和环境风险因素的复杂组合有关，这表现为 严重的运动和协调缺陷。其标志性的病理发现是聚集性 患者大脑黑质中α-突触核蛋白(α-syn)的形态。最近的研究还发现， 以前未知的α系统在黑色素瘤发生和转移中的作用，强调了α系统在 中枢神经系统以外的区域。多项研究表明，黑色素瘤细胞过度表达 α同步，这对于促进细胞的增殖和生长很重要；然而，α同步的潜在作用 体内的黑色素生成尚不清楚。我们之前已经证明了DNAsyn在αDouble- 链断裂(DSB)修复，我的新研究表明αSYN在核仁中起着重要作用。 此外，核仁内的基因组不稳定与几种与细胞有关的疾病有关。 衰老，并已被证明可诱导细胞衰老。因此，根据我的初步数据和这些 发表的研究发现，我假设α-syn的上调在细胞中起着促进核仁的关键作用 DSB修复，限制衰老，从而有助于整体细胞存活。这一假设将通过 两个目标：首先，我将确定α-syn在核仁dsb修复中的作用(目标1)，然后，确定 α突触蛋白在抑制细胞衰老和黑色素瘤生长和转移潜能中的作用(目标2)。我会完成的 这些目标是通过体外和体内方法学实现的。使用一种人类黑色素瘤细胞系 表达αSyn，SK-Mel28，我将用不同的方法研究αSyn在核仁中的定位和功能 成像和蛋白质组学技术。我将敲除αSYN以研究功能丧失的核仁表型和 细胞衰老抑制是否发生改变。然后，我将不仅重新介绍通配型α系统，还将介绍四个 神经退行性变相关的变种。检测α-Syn在黑色素瘤生长和转移中是否起作用 通过体内核仁DSB和衰老抑制，我将培育出αSyn KO自发性黑色素瘤 老鼠模型。通过组织学检查，我将确定αSyn功能丧失是否损害核仁 DSB修复和抑制衰老，延缓原发肿瘤的生长，减少转移。实现这些目标 Goals将通过引入基因组不稳定性和细胞衰老对老龄化领域产生深远影响 这些概念有助于我们理解帕金森病和黑色素瘤之间的相互作用。

PROJECT SUMMARY Genomic stability is very closely linked to diseases associated with aging, like neurodegeneration and cancer. Interestingly, strong evidence suggests unexpected links between these two diseases, since epidemiological studies have found that Parkinson’s Disease (PD) patients are at an increased risk of developing melanoma. Furthermore, this relationship is bidirectional; individuals diagnosed with melanoma are at an increased risk of developing PD. Although these clinical associations are well-established, the cellular and molecular pathways linking these diseases are poorly understood. PD is the second most common neurodegenerative disease associated with a complex combination of genetic and environmental risk factors, which manifests into devastating movement and coordination deficits. Its hallmark pathological finding is the presence of aggregated forms of alpha-synuclein (αSyn) in the substantia nigra of patient brains. Recent studies have also found a previously unrecognized role for αSyn in melanomagenesis and metastasis, highlighting the role of αSyn in regions outside of the central nervous system. Several studies have shown that melanoma cells overexpress αSyn and that this is important for promoting cell proliferation and growth; however, the underlying role of αSyn within melanogenesis is unknown. We have previously demonstrated that αSyn is important in DNA double- strand break (DSB) repair, and my new studies show an important role for αSyn within the nucleolus. Furthermore, genomic instability within the nucleolus has been associated with several diseases linked to cellular aging and has been shown to induce cellular senescence. Therefore, based on my preliminary data and these published findings, I hypothesize that the upregulation of αSyn plays a critical role in cells to facilitate nucleolar DSB repair, limit senescence, and thus contribute to overall cell survival. This hypothesis will be tested through two aims: first, I will determine the role of αSyn in nucleolar DSB repair (Aim 1) and next, determine the role of αSyn in cellular senescence inhibition and melanoma growth and metastatic potential (Aim 2). I will accomplish these goals through both in vitro and in vivo methodology. Using a human melanoma cell line that highly expresses αSyn, SK-Mel28, I will investigate the localization and function of αSyn in the nucleolus using various imaging and proteomic techniques. I will knockout αSyn to investigate loss-of-function nucleolar phenotypes and whether cellular senescence inhibition is altered. I will then reintroduce not only wildtype αSyn, but also four neurodegeneration-associated variants. To test whether αSyn plays a role in melanoma growth and metastasis through nucleolar DSB and senescence inhibition in vivo, I will breed an αSyn KO spontaneous melanoma mouse model. Through histological examination I will determine whether αSyn loss-of-function impairs nucleolar DSB repair and senescence inhibition, delays primary tumor growth, and diminishes metastasis. Achieving these goals will have a profound impact on the aging field by introducing genomic instability and cellular senescence concepts to our understanding of the cross-talk between PD and melanoma.